Showing results (81-90 of 121) with videos related to

Sort By:
Pageof 13
Arthritis and Rheumatism|February 14, 2012
Rates of malignancy associated with juvenile idiopathic arthritis and its treatmentTimothy Beukelman, Kevin Haynes, Jeffrey R Curtis, et al.
Annals of the Rheumatic Diseases|May 19, 2011
The comparative risk of serious infections among rheumatoid arthritis patients starting or switching biological agentsJeffrey R Curtis, Fenglong Xie, Lang Chen, et al.
Pediatric Rheumatology Online Journal|December 9, 2022
First-line options for systemic juvenile idiopathic arthritis treatment: an observational study of Childhood Arthritis and Rheumatology Research Alliance Consensus Treatment PlansTimothy Beukelman, George Tomlinson, Peter A Nigrovic, et al.
Annals of the Rheumatic Diseases|March 11, 2014
Risk of hospitalised infection in rheumatoid arthritis patients receiving biologics following a previous infection while on treatment with anti-TNF therapyHuifeng Yun, Fenglong Xie, Elizabeth Delzell, et al.
Arthritis Care & Research|December 28, 2019
Making Decisions About Stopping Medicines for Well-Controlled Juvenile Idiopathic Arthritis: A Mixed-Methods Study of Patients and CaregiversDaniel B Horton, Jomaira Salas, Aleksandra Wec, et al.
The Journal of Rheumatology|May 17, 2018
Risk Factors for Intraarticular Heterotopic Bone Formation in the Temporomandibular Joint in Juvenile Idiopathic ArthritisMatthew L Stoll, Dina Amin, Kathlyn K Powell, et al.
Pediatric Rheumatology Online Journal|November 16, 2018
Rituximab treatment for chronic steroid-dependent Henoch-Schonlein purpura: 8 cases and a review of the literatureCourtney B Crayne, Esraa Eloseily, Melissa L Mannion, et al.
Arthritis Care & Research|September 10, 2014
Risks of herpes zoster in patients with rheumatoid arthritis according to biologic disease-modifying therapyHuifeng Yun, Fenglong Xie, Elizabeth Delzell, et al.
Arthritis Care & Research|December 17, 2020
Juvenile Spondyloarthritis in the Childhood Arthritis and Rheumatology Research Alliance Registry: High Biologic Use, Low Prevalence of HLA-B27, and Equal Sex Representation in SacroiliitisDax G Rumsey, Aimee Lougee, Roland Matsouaka, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 29, 2015
Comparative Risk of Hospitalized Infection Associated With Biologic Agents in Rheumatoid Arthritis Patients Enrolled in MedicareHuifeng Yun, Fenglong Xie, Elizabeth Delzell, et al.
Pageof 13